Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-09-017983
Filing Date
2009-03-31
Accepted
2009-03-31 17:10:59
Documents
7
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 v144638_10k.htm 10-K 1375909
2 GRAPHIC logo1.jpg GRAPHIC 3501
3 GRAPHIC logo2.jpg GRAPHIC 2957
4 v144638_ex31-1.htm EX-31.1 10940
5 v144638_ex31-2.htm EX-31.2 11080
6 v144638_ex32-1.htm EX-32.1 6503
7 v144638_ex32-2.htm EX-32.2 6517
  Complete submission text file 0001144204-09-017983.txt   1421749
Mailing Address 409 CALLE SAN PABLO SUITE 100-101 CAMARILLO CA 93010
Business Address 409 CALLE SAN PABLO SUITE 100-101 CAMARILLO CA 93010 805-484-7687
Huifeng Bio-Pharmaceutical Technology, Inc. (Filer) CIK: 0001119951 (see all company filings)

EIN.: 870650264 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-32253 | Film No.: 09720055
SIC: 2833 Medicinal Chemicals & Botanical Products